{"id":"https://openalex.org/W1990361975","doi":"https://doi.org/10.1177/2042098614523031","title":"Safety of dipeptidyl peptidase 4 inhibitors: a perspective review","display_name":"Safety of dipeptidyl peptidase 4 inhibitors: a perspective review","alternate_titles":[],"publication_year":2014,"publication_date":"2014-02-10","ids":{"openalex":"https://openalex.org/W1990361975","doi":"https://doi.org/10.1177/2042098614523031","mag":"1990361975","pmid":"https://pubmed.ncbi.nlm.nih.gov/25083269","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4110853"},"language":"en","primary_location":{"id":"doi:10.1177/2042098614523031","doi":"https://doi.org/10.1177/2042098614523031","is_oa":false,"landing_page_url":"https://doi.org/10.1177/2042098614523031","pdf_url":null,"source":{"id":"https://openalex.org/S2764500180","display_name":"Therapeutic Advances in Drug Safety","issn_l":"2042-0986","issn":["2042-0986","2042-0994"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Drug Safety","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1990361975"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4110853/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084182369","display_name":"Thomas Karagiannis","orcid":"https://orcid.org/0000-0001-5242-0574","observed_orcids":["https://orcid.org/0000-0001-5242-0574"]},"institutions":[{"id":"https://openalex.org/I21370196","display_name":"Aristotle University of Thessaloniki","ror":"https://ror.org/02j61yw88","country_code":"GR","type":"education","lineage":["https://openalex.org/I21370196"]}],"countries":["GR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas Karagiannis","raw_affiliation_strings":["Second Medical Department, Aristotle University Thessaloniki, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Second Medical Department, Aristotle University Thessaloniki, Greece","institution_ids":["https://openalex.org/I21370196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108105900","display_name":"Panagiota Boura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I21370196","display_name":"Aristotle University of Thessaloniki","ror":"https://ror.org/02j61yw88","country_code":"GR","type":"education","lineage":["https://openalex.org/I21370196"]}],"countries":["GR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Panagiota Boura","raw_affiliation_strings":["Second Medical Department, Aristotle University Thessaloniki, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Second Medical Department, Aristotle University Thessaloniki, Greece","institution_ids":["https://openalex.org/I21370196"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018882870","display_name":"\u0391\u03c0\u03cc\u03c3\u03c4\u03bf\u03bb\u03bf\u03c2 \u03a4\u03c3\u03ac\u03c0\u03b1\u03c2","orcid":"https://orcid.org/0000-0003-0221-4072","observed_orcids":["https://orcid.org/0000-0003-0221-4072"]},"institutions":[{"id":"https://openalex.org/I21370196","display_name":"Aristotle University of Thessaloniki","ror":"https://ror.org/02j61yw88","country_code":"GR","type":"education","lineage":["https://openalex.org/I21370196"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210136534","display_name":"Manchester College","ror":"https://ror.org/03mf1cy35","country_code":"GB","type":"education","lineage":["https://openalex.org/I4210136534"]}],"countries":["GB","GR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Apostolos Tsapas","raw_affiliation_strings":["Second Medical Department, Aristotle University Thessaloniki, Greece and Harris Manchester College, University of Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Second Medical Department, Aristotle University Thessaloniki, Greece and Harris Manchester College, University of Oxford, UK","institution_ids":["https://openalex.org/I21370196","https://openalex.org/I40120149","https://openalex.org/I4210136534"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2800,"currency":"USD","value_usd":2800},"apc_paid":null,"fwci":1.5567,"has_fulltext":false,"cited_by_count":146,"citation_normalized_percentile":{"value":0.82689747,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"5","issue":"3","first_page":"138","last_page":"146"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9819999933242798},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8970000147819519},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7670000195503235},{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":0.7710000276565552},{"id":"https://openalex.org/keywords/vildagliptin","display_name":"vildagliptin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/saxagliptin","display_name":"saxagliptin","score":1.0},{"id":"https://openalex.org/keywords/linagliptin","display_name":"linagliptin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/alogliptin","display_name":"alogliptin","score":1.0},{"id":"https://openalex.org/keywords/pancreatitis","display_name":"pancreatitis","score":0.7260000109672546},{"id":"https://openalex.org/keywords/hypersensitivity","display_name":"hypersensitivity","score":0.8880000114440918},{"id":"https://openalex.org/keywords/cardiovascular-safety","display_name":"cardiovascular safety","score":0.8309999704360962},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.8379999995231628},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.8240000009536743},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.6340000033378601}],"concepts":[{"id":"https://openalex.org/C2780282729","wikidata":"https://www.wikidata.org/wiki/Q3121121","display_name":"Saxagliptin","level":5,"score":0.9670463800430298},{"id":"https://openalex.org/C2780012697","wikidata":"https://www.wikidata.org/wiki/Q4734170","display_name":"Alogliptin","level":5,"score":0.9653534889221191},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9095751047134399},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.8824410438537598},{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.7251718044281006},{"id":"https://openalex.org/C2780031085","wikidata":"https://www.wikidata.org/wiki/Q909745","display_name":"Linagliptin","level":4,"score":0.6285178661346436},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5658086538314819},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5367952585220337},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.5356029868125916},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.4764314591884613},{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.45264318585395813},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.40502557158470154},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.38833144307136536},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.333318829536438},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.12614190578460693}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1177/2042098614523031","doi":"https://doi.org/10.1177/2042098614523031","is_oa":false,"landing_page_url":"https://doi.org/10.1177/2042098614523031","pdf_url":null,"source":{"id":"https://openalex.org/S2764500180","display_name":"Therapeutic Advances in Drug Safety","issn_l":"2042-0986","issn":["2042-0986","2042-0994"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Drug Safety","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4110853","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4110853/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Adv Drug Saf","raw_type":"Text"},{"id":"pmid:25083269","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25083269","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic advances in drug safety","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4110853","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4110853/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Adv Drug Saf","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":55,"referenced_works":["https://openalex.org/W100598291","https://openalex.org/W1518038365","https://openalex.org/W1547073044","https://openalex.org/W1904160547","https://openalex.org/W1916480346","https://openalex.org/W1950171549","https://openalex.org/W1964880262","https://openalex.org/W1966002079","https://openalex.org/W1968568631","https://openalex.org/W1970638723","https://openalex.org/W1983130067","https://openalex.org/W1988068931","https://openalex.org/W2016298811","https://openalex.org/W2020292843","https://openalex.org/W2021010531","https://openalex.org/W2028317115","https://openalex.org/W2029412361","https://openalex.org/W2030113774","https://openalex.org/W2031848004","https://openalex.org/W2042702624","https://openalex.org/W2054754778","https://openalex.org/W2058468402","https://openalex.org/W2058514432","https://openalex.org/W2064130493","https://openalex.org/W2067736115","https://openalex.org/W2074881344","https://openalex.org/W2075182875","https://openalex.org/W2075207587","https://openalex.org/W2082881988","https://openalex.org/W2088748627","https://openalex.org/W2091122818","https://openalex.org/W2092287139","https://openalex.org/W2099707525","https://openalex.org/W2104079863","https://openalex.org/W2107824623","https://openalex.org/W2108292236","https://openalex.org/W2112981414","https://openalex.org/W2114792859","https://openalex.org/W2121162069","https://openalex.org/W2125653714","https://openalex.org/W2127854619","https://openalex.org/W2130243799","https://openalex.org/W2135141378","https://openalex.org/W2136259411","https://openalex.org/W2137982063","https://openalex.org/W2139255706","https://openalex.org/W2147764623","https://openalex.org/W2147970595","https://openalex.org/W2150849997","https://openalex.org/W2158506982","https://openalex.org/W2162793355","https://openalex.org/W2164535707","https://openalex.org/W2334177273","https://openalex.org/W2781184586","https://openalex.org/W4249009625"],"related_works":["https://openalex.org/W2023384663","https://openalex.org/W2069614922","https://openalex.org/W3034231623","https://openalex.org/W2335556391","https://openalex.org/W6927295460","https://openalex.org/W2104079863","https://openalex.org/W7149241568","https://openalex.org/W1547244783","https://openalex.org/W1913239326","https://openalex.org/W2124633867"],"abstract_inverted_index":{"Dipeptidyl":[0],"peptidase":[1],"4":[2],"(DPP-4)":[3],"inhibitors":[4,128],"are":[5,69],"a":[6,78,93,132],"relatively":[7],"new":[8],"class":[9],"of":[10,21,82,123,167],"oral":[11],"antihyperglycemic":[12],"agent":[13],"that":[14],"enhance":[15],"insulin":[16],"secretion":[17],"by":[18,36],"reducing":[19],"degradation":[20],"endogenous":[22],"glucagon-like":[23],"peptide":[24],"1.":[25],"Currently,":[26],"sitagliptin,":[27],"vildagliptin,":[28],"saxagliptin,":[29],"linagliptin":[30],"and":[31,40,113],"alogliptin":[32],"have":[33,76],"been":[34,60],"approved":[35],"the":[37,44,148],"US":[38],"Food":[39],"Drug":[41],"Administration":[42],"or":[43],"European":[45],"Medicines":[46],"Agency":[47],"for":[48,135],"use":[49],"in":[50],"patients":[51,136],"with":[52,137],"type":[53,138],"2":[54,139],"diabetes.":[55,140],"Their":[56],"glycemic":[57],"efficacy":[58],"has":[59,102],"well":[61],"documented;":[62],"however,":[63],"data":[64,87],"regarding":[65,121,150],"their":[66,155],"long-term":[67,169],"safety":[68,90,122],"as":[70],"yet":[71],"inconclusive.":[72],"While":[73],"preclinical":[74],"studies":[75],"indicated":[77],"potential":[79,156],"cardioprotective":[80],"effect":[81,95],"DPP-4":[83,124,127],"inhibitors,":[84],"current":[85],"clinical":[86],"from":[88],"cardiovascular":[89,97,159],"trials":[91],"suggest":[92],"neutral":[94],"on":[96,158],"outcomes.":[98],"Moreover,":[99],"postmarketing":[100],"experience":[101],"given":[103],"rise":[104],"to":[105,130,146],"concerns":[106],"about":[107],"specific":[108],"adverse":[109,152],"events,":[110,153],"including":[111],"pancreatitis":[112],"hypersensitivity":[114],"reactions.":[115],"This":[116],"review":[117],"summarizes":[118],"available":[119],"evidence":[120],"inhibitors.":[125],"Overall,":[126],"appear":[129],"be":[131,162],"safe":[133],"option":[134],"However,":[141],"close":[142],"pharmacovigilance":[143],"is":[144],"necessary":[145],"address":[147],"uncertainty":[149],"pancreas-related":[151],"while":[154],"impact":[157],"outcomes":[160],"will":[161],"further":[163],"elucidated":[164],"after":[165],"completion":[166],"more":[168],"studies.":[170]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1990361975","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":14},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":15},{"year":2018,"cited_by_count":18},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
